Gilead Sciences/ US3755581036 /
2024-11-12 9:59:56 PM | Chg. -2.72 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
94.33USD | -2.80% | 302,571 Turnover: 28.93 mill. |
-Bid Size: - | -Ask Size: - | 117.59 bill.USD | 3.18% | 20.78 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 4,502 | 4,967 | 5,121 | 5,475 | 5,317 | ||||||
Intangible Assets | 13,786 | 33,126 | 33,455 | 28,894 | 26,454 | ||||||
Long-Term Investments | 1,488 | 502 | 1,309 | 1,245 | 1,163 | ||||||
Fixed Assets | 31,331 | 52,411 | 53,180 | 48,728 | 46,040 | ||||||
Inventories | 922 | 1,683 | 1,618 | 1,507 | 1,787 | ||||||
Accounts Receivable | 3,582 | 4,892 | 4,493 | 4,777 | 4,660 | ||||||
Cash and Cash Equivalents | 11,631 | 5,997 | 5,338 | 5,412 | 6,085 | ||||||
Current Assets | 30,296 | 15,996 | 14,772 | 14,443 | 16,085 | ||||||
Total Assets | 61,627 | 68,407 | 67,952 | 63,171 | 62,125 |
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 713 | 844 | 705 | 905 | 550 | ||||||
Long-term debt | 22,094 | 28,645 | 25,179 | 22,957 | 23,189 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 38,977 | 50,186 | 46,888 | 41,962 | 39,376 | ||||||
Share Capital | 1 | 1 | 1 | 1 | 1 | ||||||
Total Equity | 22,650 | 18,221 | 21,064 | 21,209 | 22,749 | ||||||
Minority Interests | 125 | 19 | -5 | -31 | -84 | ||||||
Total liabilities equity | 61,627 | 68,407 | 67,952 | 63,171 | 62,125 |
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 22,449 | 24,689 | 27,305 | 27,281 | 27,116 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 4,287 | 4,071 | 9,918 | 7,330 | 7,605 | ||||||
Interest Income | -995 | -984 | -1,001 | -935 | -944 | ||||||
Income Before Taxes | 5,160 | 1,669 | 8,278 | 5,814 | 6,859 | ||||||
Income Taxes | -204 | 1,580 | -2,077 | -1,248 | -1,247 | ||||||
Minority Interests Profit | -22 | -34 | 24 | 26 | 52 | ||||||
Net Income | 5,386 | 123 | 6,225 | 4,592 | 5,665 |
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 9,144 | 8,168 | 11,384 | 9,072 | 8,006 | ||||||
Cash Flow from Investing Activities | -7,817 | -14,615 | -3,131 | -2,466 | -2,265 | ||||||
Cash Flow from Financing | -7,634 | 770 | -8,877 | -6,469 | -5,125 | ||||||
Decrease / Increase in Cash | -6,309 | -5,634 | -659 | 74 | 673 | ||||||
Employees | 11,800 | 13,600 | 14,000 | - | - |